Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

Abstract

The complete coding region of the p53 gene was sequenced from 316 consecutively presented breast cancers, of which 97 were lymph node positive and 206 were node negative. The p53 status was related to prognosis and effect of adjuvant therapy. In all, 69 individual mutations, 29 in node–positive tumours, were demonstrated throughout the whole coding sequence. The mutation sites were partly different for node–positive and node–negative patients. p53 mutations in the evolutionary conserved regions II and V were associated with significantly worse prognosis. Adjuvant systemic therapy, especially with tamoxifen, along with radiotherapy seemed to be of less value to p53 mutation– and lymph node–positive tumours.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339, 1–15, 71–85 (1992).

  2. Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumour suppressor gene. Nature 351, 453–456 (1991).

    Article  CAS  PubMed  Google Scholar 

  3. Vogelstein, B. & Kinzler, K.W. p53 function and dysfunction. Cell 70, 523–526 (1992).

    Article  CAS  PubMed  Google Scholar 

  4. Lane, D.P. p53, guardian of the genome. Nature 358, 15–16 (1992).

    Article  CAS  PubMed  Google Scholar 

  5. Frebourg, T. & Friend, SH. The importance of p53 gene alterations in human cancer: Is there more than circumstantial evidence? J. natn. Cancer Inst. 85, 1554–1557 (1993).

    Article  CAS  Google Scholar 

  6. Thor, A.D. et al. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J. natn. Cancer Inst. 84, 845–855 (1992).

    Article  CAS  Google Scholar 

  7. Elledge, R.M. et al. Prognostic significance of p53 gene alterations in node-negative breast cancer. Breast Cancer Res. Treatment 26, 225–235 (1993).

    Article  CAS  Google Scholar 

  8. Thorlacius, S., Börresen, A.L. & Eyfjörd, J.E. Somatic p53 mutations in human breast carcinomas in an Icelandic population: A prognostic factor. Cancer Res. 53, 1637–1641 (1993).

    CAS  PubMed  Google Scholar 

  9. Bartek, J., Iggo, R., Gannon, J. & Lane, D.P. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5, 893–899 (1990).

    CAS  PubMed  Google Scholar 

  10. Banks, L., Matlashewski, G. & Crawford, L. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159, 529–534 (1986).

    Article  CAS  PubMed  Google Scholar 

  11. Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L. & Delia, D. p53 expression in breast cancer. Int. J. Cancer 41, 178–183 (1988).

    Article  CAS  PubMed  Google Scholar 

  12. Bartek, J. et al. Patterns of expression of the p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int. J. Cancer 46, 839–844 (1990).

    Article  CAS  PubMed  Google Scholar 

  13. Davidoff, A.M. et al. Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 110, 259–264 (1991).

    CAS  PubMed  Google Scholar 

  14. Ostrowski, J.L. et al. p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study. J. Pathol. 164, 75–81 (1991).

    Article  CAS  PubMed  Google Scholar 

  15. Cho, Y., Gorina, S., Jeffery, P.D. & Pavletich, N.P. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265, 346–355 (1994).

    Article  CAS  PubMed  Google Scholar 

  16. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957–967 (1993).

    Article  CAS  PubMed  Google Scholar 

  17. Fujiwara, T. et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54, 2287–2291 (1994).

    CAS  PubMed  Google Scholar 

  18. Wilson, A.C., Singh, M. & Thompson, H.J. Morphological responses of MOD cells to tamoxifen suggests induction of apoptosis. Proc. Annu. Meet. Am. Assoc. Cancer Res. abstract 903 (1992).

  19. Lim, J.S., Ly, A., Bhimani, R., Frenkel, K. & Troll, W. The chemopreventive agent tamoxifen causes apoptosis. Proc. Annu. Meet. Am. Assoc. Cancer Res. abstract 3693 (1994).

  20. O'Connor, P.M. et al. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53, 4776–4780 (1993).

    CAS  PubMed  Google Scholar 

  21. Lowe, S.W. et al. p53 status and the efficacy of cancer therapy. Science 266, 807–810 (1994).

    Article  CAS  PubMed  Google Scholar 

  22. Ory, K., Legros, Y., Auguin, C. & Soussi, T. Analysis of the most representative tumor-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J. 13, 3496–3504 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Liljegren, G. et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer; five year results of a randomized trial. J. natn. Cancer Inst. 86, 717–722 (1994).

    Article  CAS  Google Scholar 

  24. Ståhl, S., Hultman, T., Olsson, A., Moks, T. & Uhlén, M. Solid phase DNA sequencing using the biotin-avidin system. Nucl. Acids Res. 16, 3025–3038 (1988).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lagerkvist, A., Stewart, J., Lagerström-Fermér, M. & Landegren, U. Manifold sequencing: Efficient processing of large sets of sequencing reactions. Proc. natn. Acad. Sci. U.SA. 91, 2245–2249 (1994).

    Article  CAS  Google Scholar 

  26. Cox, D.R. Regression models and life-tables (with discussion). J. Royal Stat. Soc. B 34, 187–220 (1972).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergh, J., Norberg, T., Sjögren, S. et al. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1, 1029–1034 (1995). https://doi.org/10.1038/nm1095-1029

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1095-1029

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing